Literature DB >> 25854363

Effect of autophagy-related beclin1 on sensitivity of cisplatin-resistant ovarian cancer cells to chemotherapeutic agents.

Yang Sun1, Jia-Hua Liu, Long Jin, Yu-Xia Sui, Li-Li Han, Yin Huang.   

Abstract

The purpose of the study was to determine the effects of autophagy related gene Beclin1 at different levels of expression on the sensitivity of cisplatin-resistant ovarian cancer cells (SKOV3/DDP) to different chemotherapeutics. In pSUPER-Beclin1 transfected cells, real-time fluorescence quantitative RT-PCR and Western blot analysis showed that expression was significantly inhibited. Flow cytometry revealed that the mean fluorescence intensity (MDC), reflecting autophagy, and cells in the G0/G1 phase were markedly reduced. When compared with the blank control group, inhibition of Beclin1 expression in SKOV3/DDP cells not only increased the rate of apoptosis following treatment with chemotherapeutics, but also increased the sensitivity. These findings suggest that Beclin1 expression plays an important role in chemotherapeutic agent-induced death of SKOV3/DDP cells. Inhibition of autophagy related gene Beclin1 expression in SKOV3/DDP cells may increase the rate of apoptosis and elevate the sensitivity to chemotherapeutics.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25854363     DOI: 10.7314/apjcp.2015.16.7.2785

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  11 in total

1.  MicroRNA-199a-5p inhibits cisplatin-induced drug resistance via inhibition of autophagy in osteosarcoma cells.

Authors:  Yusheng Li; Wei Jiang; Yuling Hu; Zixun Da; Chao Zeng; Min Tu; Zhenhan Deng; Wenfeng Xiao
Journal:  Oncol Lett       Date:  2016-09-22       Impact factor: 2.967

2.  Phyllanthusmin Derivatives Induce Apoptosis and Reduce Tumor Burden in High-Grade Serous Ovarian Cancer by Late-Stage Autophagy Inhibition.

Authors:  Alexandria N Young; Denisse Herrera; Andrew C Huntsman; Melissa A Korkmaz; Daniel D Lantvit; Sarmistha Mazumder; Shamalatha Kolli; Christopher C Coss; Salane King; Hongyan Wang; Steven M Swanson; A Douglas Kinghorn; Xiaoli Zhang; Mitch A Phelps; Leslie N Aldrich; James R Fuchs; Joanna E Burdette
Journal:  Mol Cancer Ther       Date:  2018-07-17       Impact factor: 6.261

3.  Cisplatin induces protective autophagy through activation of BECN1 in human bladder cancer cells.

Authors:  Ji-Fan Lin; Yi-Chia Lin; Te-Fu Tsai; Hung-En Chen; Kuang-Yu Chou; Thomas I-Sheng Hwang
Journal:  Drug Des Devel Ther       Date:  2017-05-16       Impact factor: 4.162

Review 4.  Autophagy as an emerging therapy target for ovarian carcinoma.

Authors:  Lei Zhan; Yu Zhang; Wenyan Wang; Enxue Song; Yijun Fan; Jun Li; Bing Wei
Journal:  Oncotarget       Date:  2016-12-13

5.  Association between circadian gene CLOCK and cisplatin resistance in ovarian cancer cells: A preliminary study.

Authors:  Hai Xu; Zhiyin Wang; Guoyan Mo; Hao Chen
Journal:  Oncol Lett       Date:  2018-04-13       Impact factor: 2.967

6.  Prognostic significance of autophagy-related genes Beclin1 and LC3 in ovarian cancer: a meta-analysis.

Authors:  Xinbei Chen; Yang Sun; Bingrong Wang; Huihui Wang
Journal:  J Int Med Res       Date:  2020-11       Impact factor: 1.671

7.  Increased autophagy in EOC re-ascites cells can inhibit cell death and promote drug resistance.

Authors:  Yu Liu; Jing Tang; Duanyang Liu; Lei Zhang; Yan He; Jing Li; Lei Gao; Dai Tang; Xiaoming Jin; Dan Kong
Journal:  Cell Death Dis       Date:  2018-04-01       Impact factor: 8.469

8.  MicroRNA-142-3p inhibits cell proliferation and chemoresistance in ovarian cancer via targeting sirtuin 1.

Authors:  Jianlian Gao; Nan Wu; Xiaohong Liu; Yuechong Xia; Ying Chen; Shaoru Li; Zhijian Deng
Journal:  Exp Ther Med       Date:  2018-04-27       Impact factor: 2.447

9.  Targeting V-ATPase Isoform Restores Cisplatin Activity in Resistant Ovarian Cancer: Inhibition of Autophagy, Endosome Function, and ERK/MEK Pathway.

Authors:  Arpita Kulshrestha; Gajendra K Katara; Safaa A Ibrahim; Valerie Riehl; Manoranjan Sahoo; James Dolan; Kyle W Meinke; Michael R Pins; Kenneth D Beaman
Journal:  J Oncol       Date:  2019-04-01       Impact factor: 4.375

Review 10.  Molecular Mechanisms Underlying Autophagy-Mediated Treatment Resistance in Cancer.

Authors:  Cally J Ho; Sharon M Gorski
Journal:  Cancers (Basel)       Date:  2019-11-11       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.